Effects of m6A modifications on signaling pathways in human cancer (Review)

12Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

N6-methyladenosine (m6A) is one of the most prev- alent post-transcriptional RNA modifications. The enzymes involved in the regulation of m6A include methyltransferase (writers), demethylase (erasers) and m6A recognition proteins (readers). Accumulating studies have demonstrated that m6A modifications have a distinct effect on various biological processes, including tumorigenesis, cell differentiation, embryonic development and neurogenic diseases, while our knowledge of the specific mechanism underlying m6A methylation in various cancer types is still limited. Various signaling pathways have an effect on tumorigenesis, inva- sion and apoptosis of malignant tumors. The present review summarizes the recent progress in research regarding the role of m6A in human cancer and discusses the influence of m6A on classic signaling pathways in malignant tumors.

Cite

CITATION STYLE

APA

Liu, F., & Su, X. (2021, April 1). Effects of m6A modifications on signaling pathways in human cancer (Review). Oncology Reports. Spandidos Publications. https://doi.org/10.3892/or.2021.7987

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free